Concepedia

Author

Beverley Isherwood

AstraZeneca (United Kingdom)ORCID

Also Known As

B. Isherwood, Bev Isherwood, Beverley Isherwood, Beverley J. Isherwood, Beverly Isherwood

18

Publications

588

Citations

9

H-Index

29

Concepts

All Affiliations

AstraZeneca (United Kingdom)Loughborough UniversityEdinburgh Cancer Research
BI

About

Beverley Isherwood is an author at AstraZeneca (United Kingdom) specializing in engineering, cell biology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

3

3

141

2

Medicine

3

3

141

3

Cell Biology

3

3

141

4

Biomedical Engineering

2

2

127

5

Biostatistics

1

1

14

Beverley Isherwood

×

8

Publications

536

Citations

8

H-Index

YearCitations

Reassortment In Vivo: Driving Force for Diversity of Human Rotavirus Strains Isolated in the United Kingdom between 1995 and 1999

Miren Iturriza‐Gómara, Beverley Isherwood, Ulrich Desselberger,

Journal of Virology

2001

272

Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery

Beverley Isherwood, Paul Timpson, Ewan J. McGhee,

Pharmaceutics

2011

79

High speed unsupervised fluorescence lifetime imaging confocal multiwell plate reader for high content analysis

Clifford Talbot, James McGinty, David M. Grant,

Journal of Biophotonics

2008

48

Analysis of the processing and transmembrane topology of the E2p7 protein of hepatitis C virus

Beverley Isherwood, Arvind H. Patel

Journal of General Virology

2005

36

Large‐scale isolation of human skeletal muscle satellite cells from post‐mortem tissue and development of quantitative assays to evaluate modulators of myogenesis

Ian Scott, Wendy Tomlinson, Andrew Walding,

Journal of Cachexia Sarcopenia and Muscle

2013

31

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors

Shanade Dunn, Cath Eberlein, Jason Yu,

Oncogene

2022

30

Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles

Douglas Ross‐Thriepland, Aurélie Bornot, Larissa Butler,

SLAS DISCOVERY

2020

26

High-Content Analysis to Leverage a Robust Phenotypic Profiling Approach to Vascular Modulation

Beverley Isherwood, Rebecca E. Walls, Mark Roberts,

SLAS DISCOVERY

2013

14

Page 1